CHRNB1 and Parkinson disease: Three replicated genes encode targets of approved or clinical-phase drugs with an appropriate direction of effect for PD protection, presenting a possible repurposing opportunity: CHRNB1, NDUFAF2 and VKORC1 (Table 1 and Supplementary Data 1).